about
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility MappingQuantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of ironMultiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.Left ventricle: fully automated segmentation based on spatiotemporal continuity and myocardium information in cine cardiac magnetic resonance imaging (LV-FAST)Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendorsThe Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI.Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility MappingQuantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.Flow compensated quantitative susceptibility mapping for venous oxygenation imaging.Vastly accelerated linear least-squares fitting with numerical optimization for dual-input delay-compensated quantitative liver perfusion mapping.Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation.Coherence enhancement in quantitative susceptibility mapping by means of anisotropic weighting in morphology enabled dipole inversion.Primal-dual and forward gradient implementation for quantitative susceptibility mapping.The influence of molecular order and microstructure on the R2* and the magnetic susceptibility tensor.Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map.In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis.Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions.MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping.Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations.Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.Fast and Robust Unsupervised Identification of MS Lesion Change Using the Statistical Detection of Changes Algorithm.Motion artifact suppression in breath hold 3D contrast enhanced magnetic resonance angiography using ECG ordering.Cerebral Metabolic Rate of Oxygen (CMRO2 ) Mapping by Combining Quantitative Susceptibility Mapping (QSM) and Quantitative Blood Oxygenation Level-Dependent Imaging (qBOLD).Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping.Multiple regions of interest on multi-parametric magnetic resonance imaging are not associated with increased detection of clinically significant prostate cancer on fusion biopsy.Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.Brain Injury Lesion Imaging Using Preconditioned Quantitative Susceptibility Mapping without Skull Stripping.Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencingClinical Integration of Quantitative Susceptibility Mapping (QSM) MRI into Neurosurgical PracticeRegion-specific susceptibility change in cognitively impaired patients with diabetes mellitusComprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's diseaseCluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mappingQuantitative susceptibility mapping of carotid plaques using nonlinear total field inversion: Initial experience in patients with significant carotid stenosisPatents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism
P50
Q26771174-B265CB53-4F06-4600-B653-70A6602064D3Q30843585-6C127A5F-F0A6-42FF-B772-687DAF220ED6Q30846734-51BA9C9C-46E8-4A68-9A39-AFE30F42C7ACQ35109495-3BA62098-1E6E-4360-ACC4-A032B0C34ED3Q36322681-3D59844A-3D40-40B1-954F-B4D3AE96DE82Q36376073-29779170-146F-43ED-9EAD-5B3B7CBEDEB8Q36732418-93ECA2BD-06E8-41CA-A64B-213063A9296BQ36902028-B8BA707D-8000-4E6A-99B5-0B7C5AE459B3Q37099099-6742CABE-FA86-4874-9489-F0087E225E80Q37246750-0EB45A39-C48A-406B-B892-BC17D3ED4E4BQ37691877-BF6CFFA9-3FBE-4629-BE5C-FA79644A2F2BQ38612074-D7C5BB5F-9566-4BE2-8296-3C7970011672Q38707672-43F115DB-41E3-4422-8DB1-05BC8D56D51BQ38757473-AFA24CA2-FF78-4B3A-907E-5310119DF38AQ38934170-ABA6C217-9D02-427C-86B5-025B4C31C94AQ40182901-6A0BDEF4-0505-4773-AD3D-0116BBEB4F9BQ40281880-6EE296B2-B56A-4ACD-8E86-A2011DC02446Q46147833-CFEE8BFA-760F-4A92-B2EA-B3E5ED597F31Q47248437-8EB52EDE-9594-4944-AE16-B25284E29C2AQ47553880-E915649D-FA35-498D-8FE5-92AFCE6C1ED5Q47576200-53A7829B-B762-4827-A9C4-45DA3E2F89A1Q47694579-8B1DB9F2-C172-46DF-88DA-4C8F58860E77Q48163868-1D05428E-98C6-43A5-AC90-4A1F1D45A23CQ48179143-20C10D49-62AD-4BD1-AED3-0A707F3D9CABQ51742620-F22E2CD8-8155-411E-8682-7C7E9CB4A719Q51902873-D3FB2843-47C2-4A99-B28C-E2C05DBF4537Q52363270-55D50706-85D6-4E22-9E86-2102FE4C7F19Q52642520-BDC20E5A-6778-412F-9723-FA4BF5A7E499Q52652488-C57BF1E2-A7B2-429C-822C-23861BAC5D06Q52666641-8E9172DB-EEE9-4E80-BBBB-567DDEFD2D44Q52666936-A7FF8105-2BAE-4843-96B2-B3104955A9F2Q52677402-EE29FCDB-D972-425E-86FD-24F27B7D1A04Q52689253-B5F9215A-399D-420A-8EC3-3A3E93F286D7Q57029493-0B4AC1C7-3375-4999-A0B0-47D04A25A91DQ57100085-1AF7BF04-4546-41DF-B0B7-DFAD60F0588BQ57281683-1EA0C988-3C93-4917-8FD4-69890697A4E5Q64795557-05E70A1B-32C0-4B17-8340-EDFDA225F7BAQ90014607-252BF02A-9088-4F35-B98B-1FBD82060BE8Q90105401-14809AA4-0CFA-435A-89EE-A4A05DAD05A3Q90578704-0F2341FE-F78E-46FA-8A93-AA6E37FF3BBE
P50
description
researcher ORCID ID = 0000-0003-1404-8526
@en
name
Yi Wang
@ast
Yi Wang
@en
Yi Wang
@nl
ওয়াং ই
@bn
type
label
Yi Wang
@ast
Yi Wang
@en
Yi Wang
@nl
ওয়াং ই
@bn
prefLabel
Yi Wang
@ast
Yi Wang
@en
Yi Wang
@nl
ওয়াং ই
@bn
P106
P2456
P31
P496
0000-0003-1404-8526